VWR Acquires United Biochemicals
News Jul 05, 2013
Based in Sanborn, New York and founded in 1996, United Biochemicals manufactures and supplies high purity buffers and biochemicals for research, development and manufacturing processes to biotech, pharmaceutical, cell culture media and medical diagnostic industries.
"United Biochemicals is a strong compliment to VWR's growing life sciences portfolio as VWR continues to make strategic investment into our business," said Manuel Brocke-Benz, President and CEO of VWR. "United Biochemicals' manufacturing expertise, combined with VWR's existing platform of chemical manufacturing assets, enhances our current offering to our biotech and pharmaceutical customers and strengthens our position in the industry."
"We are excited to join a trusted, global brand like VWR," shared Fayyaz Hussain, President of United Biochemicals. "This acquisition will allow United Biochemicals to leverage VWR's global sales and marketing organization to grow our business."
Financial details of this acquisition remain confidential.
Researchers have created a portable and fast-acting test that can distinguish Ebola infections from other fever-causing infectious diseases such as Lassa fever and malaria in around 30 minutes. Although further testing is required, this could be useful during febrile disease outbreaks.READ MORE